Department of Pharmacology Archives
Mar. 3, 2016—Joseph Coyle, M.D., an expert in the neurobiology of serious mental illness, will deliver the next Flexner Discovery Lecture on Thursday, March 10.
Feb. 25, 2016—C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.
Jan. 21, 2016—BethAnn McLaughlin, Ph.D., a neuroscientist at Vanderbilt University Medical Center, has been invited to serve as a reviewing editor for the Journal of Neuroscience, the flagship publication of the Society of Neuroscience, one of the world’s largest scientific societies.
Jan. 14, 2016—A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells.
Nov. 5, 2015—Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.
Oct. 1, 2015—La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.
Aug. 13, 2015—New findings show that fibrin, a protein that was thought to play a key role in fracture healing, is not required, shifting understanding of how fractures heal.